financetom
Business
financetom
/
Business
/
Home Bancshares Insider Sold Shares Worth $753,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Home Bancshares Insider Sold Shares Worth $753,000, According to a Recent SEC Filing
Nov 9, 2024 12:34 PM

03:32 PM EST, 11/07/2024 (MT Newswires) -- Jack Engelkes, Director, on November 06, 2024, sold 25,000 shares in Home Bancshares ( HOMB ) for $753,000. Following the Form 4 filing with the SEC, Engelkes has control over a total of 411,101 shares of the company, with 205,195 shares held directly and 205,906 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1331520/000133152024000180/xslF345X05/wk-form4_1731011251.xml

Price: 29.56, Change: -1.21, Percent Change: -3.93

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Norfolk Southern Team, Strategy Unlikely to Change Following Ancora Proxy Fight, UBS Says
Norfolk Southern Team, Strategy Unlikely to Change Following Ancora Proxy Fight, UBS Says
May 10, 2024
03:51 PM EDT, 05/10/2024 (MT Newswires) -- Norfolk Southern's ( NSC ) executive team or strategy is unlikely to change after the railway company's shareholders elected a majority of its director nominees, including Chief Executive Alan Shaw, who survived activist investor Ancora's attempt to oust him, UBS Securities said in a note e-mailed Friday. A preliminary vote count showed Thursday...
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone
May 10, 2024
03:32 PM EDT, 05/10/2024 (MT Newswires) -- Alpine Immune Sciences ( ALPN ) and Vertex Pharmaceuticals ( VRTX ) said Friday the waiting period under the Hart-Scott-Rodino antitrust act related to their merger deal expired Thursday. Vertex has agreed to acquire Alpine for $4.9 billion in cash, or $65 a share. Price: 64.94, Change: +0.12, Percent Change: +0.19 ...
Market Chatter: Cipla Open to Partner With Eli Lilly to Market Obesity Drugs in India
Market Chatter: Cipla Open to Partner With Eli Lilly to Market Obesity Drugs in India
May 10, 2024
03:45 PM EDT, 05/10/2024 (MT Newswires) -- Eli Lilly ( LLY ) could partner with Indian drugmaker Cipla to market its weight-loss drugs in India, Reuters reported Friday, citing Cipla's Global CEO Umang Vohra. Cipla has an existing partnership to distribute and market Lilly's diabetes medicines in India, according to the report. Global demand for Eli Lilly's ( LLY )...
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing
May 10, 2024
03:32 PM EDT, 05/10/2024 (MT Newswires) -- Brett Sandercock, Chief Financial Officer, on May 08, 2024, sold 13,000 shares in Resmed ( RMD ) for $2,747,810. Following the Form 4 filing with the SEC, Sandercock has control over a total of 92,056 shares of the company, with 92,056 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943819/000112760224014978/xslF345X03/form4.xml Price: 214.16, Change: -2.69, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved